Heggie Theresa

Heggie Theresa is listed in filings as Director at BioCryst Pharmaceuticals Inc. This profile follows SEC Form 4 activity through Mar 24, 2026, including sale activity. Recent filings connect the profile to BioCryst Pharmaceuticals Inc (BCRX). The current snapshot covers public activity from Jun 14, 2024 to Mar 24, 2026. Reported amounts are shown as $314.6K to $282.7K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.